Successful Treatment of Mitomycin-induced Thrombotic Thrombocytopenic Purpura with Rituximab

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 2, 2009, Pages 275-276

  Onitilo, Adedayo A ^a   Engel, Jessica M ^a   Clouse, Lawrence H ^a   Gerndt, Kristin M ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DAUNORUBICIN; DEXAMETHASONE; MITOMYCIN C; PACLITAXEL; PREDNISONE; RITUXIMAB;

AGED; ANAMNESIS; BREAST ADENOCARCINOMA; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LETTER; LIVER INJURY; LOW DRUG DOSE; LUNG ADENOCARCINOMA; MULTIPLE CYCLE TREATMENT; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MITOMYCIN; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 58349093114     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.10.025     Document Type: Letter

References (6)

1. Giroux L., Bettez P., and Giroux L. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. Am J Kidney Dis 6 (1985) 28-39
2. Cantrell Jr. J.E., Phillips T.M., and Schein P.S. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 3 (1985) 723-734
3. Durand J.M., and Lefevre P. Mitomycin-induced thrombotic thrombocytopenic purpura: possible successful treatment with vincristine and cyclophosphamide. Haematologica 76 (1991) 421-423
4. Kasper S., Neurath M.F., Huber C., Theobald M., and Scharrer I. Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy. Transfusion 47 (2007) 1263-1267
5. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141 (2008) 149-169
6. Onitilo A.A., Skorupa A., Lal A., et al. Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost 96 (2006) 84-87